Alliance Foundation Trials, SOLTI, Novartis launch HARMONIA, an international phase III study for selected patients with aggressive HR+/HER2- advanced breast cancer

September 17, 2021

  • HARMONIA is the first prospective phase III trial to enroll selected patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) identified using an RNA-based subtype classification
  • The trial seeks to

Research Call for Investigators - TransPALLAS

September 15, 2021

The TransPALLAS Committee today announced a Research Call for Investigators for the PALLAS study. 

The following three documents provide more details about the research call:

Trans-PALLAS Overview Research Calls for Investigators
PALLAS-Research Proposal Checklist
PALLAS-Research Project Proposal Submission Form

New Trial Alert: Alliance A021901 Bronchial Neuroendocrine Tumors

September 10, 2021

Alliance A021901: Randomized phase II trial of lutetium Lu 177 dotatate versus everolimus in somatostatin receptor positive bronchial neuroendocrine tumors

Overview: Alliance investigator Thomas Hope, MD, of the University of California San Francisco, leads this phase II trial that studies the effect of lutetium Lu 177 dotatate compared to the usual treatment (everolimus) in treating patients with

Older News